Literature DB >> 22766231

A sensitive LC-MS/MS assay for the simultaneous analysis of the major active components of silymarin in human plasma.

Bryan J Brinda1, Hao-Jie Zhu, John S Markowitz.   

Abstract

Silymarin, an extract of crushed achenes of the milk thistle plant Silybum marianum is a multi-constituent mixture, 70-80% of which consists of a complex assortment containing the flavonolignans silybin A and B, isosilybin A and B, silydianin, and silychristin, and the flavonoid taxifolin. To date, numerous pharmacological actions of the silymarin extract have been documented in the biomedical literature, including hepatoprotective, anti-inflammatory, anti-tumor, and anti-fibrotic activities. The present study describes a novel liquid chromatographic-tandem mass spectrometric method for simultaneous analysis of silychristin, silydianin, silybin A and silybin B, isosilybin A and isosilybin B, and taxifolin in human plasma employing liquid-liquid extraction. This assay provides excellent resolution of the individual silymarin constituents via utilization of a 100 A 250 mm × 2 mm, 5 μm C(18) column with the mobile phase consisting of 51% methanol, 0.1% formic acid, and 10mM ammonium acetate. The lower limit of quantification was 2 ng/ml for each constituent. Calibration curves were linear over the range from 2 ng/ml to 100 ng/ml for all analytes (r(2)>0.99). The intra- and inter-day accuracies were 91-106.5% and 95.1-111.9%, respectively. The intra- and inter-day precision was within 10.5%. Additionally, recovery, stability, and matrix effects were fully validated as well. This method was successfully applied to human plasma samples from subjects treated with the milk thistle extract Legalon(®).
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22766231     DOI: 10.1016/j.jchromb.2012.06.003

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

1.  Effect of silymarin in the prevention of Cisplatin nephrotoxicity, a clinical trial study.

Authors:  Ali Momeni; Ali Hajigholami; Shohreh Geshnizjani; Soleiman Kheiri
Journal:  J Clin Diagn Res       Date:  2015-04-01

2.  The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity.

Authors:  Marina Kawaguchi-Suzuki; Reginald F Frye; Hao-Jie Zhu; Bryan J Brinda; Kenneth D Chavin; Hilary J Bernstein; John S Markowitz
Journal:  Drug Metab Dispos       Date:  2014-07-15       Impact factor: 3.922

3.  Relative Bioavailability of Silybin A and Silybin B From 2 Multiconstituent Dietary Supplement Formulations Containing Milk Thistle Extract: A Single-dose Study.

Authors:  Wen-Yi Li; Guo Yu; Renee M Hogan; Rajesh Mohandas; Reginald F Frye; Eric Gumpricht; John S Markowitz
Journal:  Clin Ther       Date:  2017-12-19       Impact factor: 3.393

4.  Single Laboratory Validation of UHPLC-MS/MS Assays for Six Milk Thistle Flavonolignans in Human Serum.

Authors:  Ruth N Muchiri; Richard B van Breemen
Journal:  J AOAC Int       Date:  2021-03-05       Impact factor: 1.913

5.  An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study.

Authors:  Hao-Jie Zhu; Bryan J Brinda; Kenneth D Chavin; Hilary J Bernstein; Kennerly S Patrick; John S Markowitz
Journal:  Drug Metab Dispos       Date:  2013-07-08       Impact factor: 3.579

6.  Enhanced Bioavailability and Efficacy of Silymarin Solid Dispersion in Rats with Acetaminophen-Induced Hepatotoxicity.

Authors:  Im-Sook Song; So-Jeong Nam; Ji-Hyeon Jeon; Soo-Jin Park; Min-Koo Choi
Journal:  Pharmaceutics       Date:  2021-04-28       Impact factor: 6.321

7.  Antrodia camphorata-Derived Antrodin C Inhibits Liver Fibrosis by Blocking TGF-Beta and PDGF Signaling Pathways.

Authors:  Xin-Yi Xu; Yan Geng; Hao-Xiang Xu; Yilin Ren; Deng-Yang Liu; Yong Mao
Journal:  Front Mol Biosci       Date:  2022-02-15

8.  Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo.

Authors:  Sílvia Cufí; Rosa Bonavia; Alejandro Vazquez-Martin; Cristina Oliveras-Ferraros; Bruna Corominas-Faja; Elisabet Cuyàs; Begoña Martin-Castillo; Enrique Barrajón-Catalán; Joana Visa; Antonio Segura-Carretero; Jorge Joven; Joaquim Bosch-Barrera; Vicente Micol; Javier A Menendez
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

9.  The Bioavailability and Pharmacokinetics of Silymarin SMEDDS Formulation Study in Healthy Thai Volunteers.

Authors:  Chuleegone Sornsuvit; Darunee Hongwiset; Songwut Yotsawimonwat; Manatchaya Toonkum; Satawat Thongsawat; Wandee Taesotikul
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-19       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.